IRF4 and Parkinson disease: Besides, pathways including Oxidative-phosphorylation (Figure 3E), Citrate-cycle-tca-cycle (Figure 3F), Parkinsons-disease (Figure 3G) and Huntingtons-disease (Figure 3H) were maximum extent enriched in IRF4 low expression subgroup.